Global EZH2 Inhibitors Market Size, Share, and COVID-19 Impact Analysis, By Type of Therapy (Monotherapy and Combination Therapy), By End Users (Hospitals, Research Laboratories, and Clinics), and By Region (North America, Europe, Asia Pacific, Latin America, Middle East, and Africa), Analysis and Forecast 2023 - 2033

Industry: Healthcare
RELEASE DATE Jan 2025
REPORT ID SI7781
PAGES 220
REPORT FORMAT PathSoft
Request Free Sample
Description Table of Contents Scope of Report Methodology
  1. Introduction
    1. Objectives of the Study
    2. Market Definition
    3. Research Scope
  2. Research Methodology and Assumptions
  3. Executive Summary
  4. Premium Insights
    1. Porter’s Five Forces Analysis
    2. Value Chain Analysis
    3. Top Investment Pockets
      1. Market Attractiveness Analysis By Type of Therapy
      2. Market Attractiveness Analysis By End Users
      3. Market Attractiveness Analysis By Region
    4. Industry Trends
  5. Market Dynamics
    1. Market Evaluation
    2. Drivers
      1. Rising cancer prevalence & epigenetic research
    3. Restraints
      1.   High development costs & off-target effects
    4. Opportunities
      1.  Increased investment in R&D activities by manufacturers
    5. Challenges
      1.      New indications & strategic partnerships
  6. Global EZH2 Inhibitors Market Analysis and Projection, By Type of Therapy
    1. Segment Overview
    2. Monotherapy
    3. Combination Therapy
  7. Global EZH2 Inhibitors Market Analysis and Projection, By End Users
    1. Segment Overview
    2. Hospitals
    3. Research Laboratories
    4. Clinics
  8. Global EZH2 Inhibitors Market Analysis and Projection, By Regional Analysis
    1. Segment Overview
    2. North America
      1. U.S.
      2. Canada
      3. Mexico
    3. Europe
      1. Germany
      2. France
      3. U.K.
      4. Italy
      5. Spain
    4. Asia-Pacific
      1. Japan
      2. China
      3. India
    5. South America
      1. Brazil
    6. Middle East and Africa
      1. UAE
      2. South Africa
  9. Global EZH2 Inhibitors Market-Competitive Landscape
    1. Overview
    2. Market Share of Key Players in the EZH2 Inhibitors Market
      1. Global Company Market Share
      2. North America Company Market Share
      3. Europe Company Market Share
      4. APAC Company Market Share
    3. Competitive Situations and Trends
      1. Coverage Launches and Developments
      2. Partnerships, Collaborations, and Agreements
      3. Mergers & Acquisitions
      4. Expansions
  10. Company Profiles
    1. Merck
      1. Business Overview
      2. Company Snapshot
      3. Company Market Share Analysis
      4. Company Coverage Portfolio
      5. Recent Developments
      6. SWOT Analysis
    2.   Athenex 
      1. Business Overview
      2. Company Snapshot
      3. Company Market Share Analysis
      4. Company Coverage Portfolio
      5. Recent Developments
      6. SWOT Analysis
    3.  Prelude Therapeutics 
      1. Business Overview
      2. Company Snapshot
      3. Company Market Share Analysis
      4. Company Coverage Portfolio
      5. Recent Developments
      6. SWOT Analysis
    4.   Novartis 
      1. Business Overview
      2. Company Snapshot
      3. Company Market Share Analysis
      4. Company Coverage Portfolio
      5. Recent Developments
      6. SWOT Analysis
    5.   AstraZeneca 
      1. Business Overview
      2. Company Snapshot
      3. Company Market Share Analysis
      4. Company Coverage Portfolio
      5. Recent Developments
      6. SWOT Analysis
    6.  Silence Therapeutics
      1. Business Overview
      2. Company Snapshot
      3. Company Market Share Analysis
      4. Company Coverage Portfolio
      5. Recent Developments
      6. SWOT Analysis
    7.   Incyte
      1. Business Overview
      2. Company Snapshot
      3. Company Market Share Analysis
      4. Company Coverage Portfolio
      5. Recent Developments
      6. SWOT Analysis
    8. Celgene
      1. Business Overview
      2. Company Snapshot
      3. Company Market Share Analysis
      4. Company Coverage Portfolio
      5. Recent Developments
      6. SWOT Analysis
    9.  Zymeworks
      1. Business Overview
      2. Company Snapshot
      3. Company Market Share Analysis
      4. Company Coverage Portfolio
      5. Recent Developments
      6. SWOT Analysis
    10.  Janssen Biotech 
      1. Business Overview
      2. Company Snapshot
      3. Company Market Share Analysis
      4. Company Coverage Portfolio
      5. Recent Developments
      6. SWOT Analysis
    11.  GSK
      1. Business Overview
      2. Company Snapshot
      3. Company Market Share Analysis
      4. Company Coverage Portfolio
      5. Recent Developments
      6. SWOT Analysis
    12.   Epizyme
      1. Business Overview
      2. Company Snapshot
      3. Company Market Share Analysis
      4. Company Coverage Portfolio
      5. Recent Developments
      6. SWOT Analysis
    13.  NantKwest 
      1. Business Overview
      2. Company Snapshot
      3. Company Market Share Analysis
      4. Company Coverage Portfolio
      5. Recent Developments
      6. SWOT Analysis
    14.  Others
      1. Business Overview
      2. Company Snapshot
      3. Company Market Share Analysis
      4. Company Coverage Portfolio
      5. Recent Developments
      6. SWOT Analysis

 

List of Table

  1. Global EZH2 Inhibitors Market, By Type of Therapy, 2023-2033(USD Billion)
  2. Global Monotherapy, EZH2 Inhibitors Market, By Region, 2023-2033(USD Billion)
  3. Global Combination Therapy, EZH2 Inhibitors Market, By Region, 2023-2033(USD Billion)
  4. Global EZH2 Inhibitors Market, By End Users, 2023-2033(USD Billion)
  5. Global Hospitals, EZH2 Inhibitors Market, By Region, 2023-2033(USD Billion)
  6. Global Research Laboratories, EZH2 Inhibitors Market, By Region, 2023-2033(USD Billion)
  7. Global Clinics, EZH2 Inhibitors Market, By Region, 2023-2033(USD Billion)
  8. North America EZH2 Inhibitors Market, By Type of Therapy, 2023-2033(USD Billion)
  9. North America EZH2 Inhibitors Market, By End Users, 2023-2033(USD Billion)
  10. U.S.  EZH2 Inhibitors Market, By Type of Therapy, 2023-2033(USD Billion)
  11. U.S.  EZH2 Inhibitors Market, By End Users, 2023-2033(USD Billion)
  12. Canada EZH2 Inhibitors Market, By Type of Therapy, 2023-2033(USD Billion)
  13. Canada EZH2 Inhibitors Market, By End Users, 2023-2033(USD Billion)
  14. Mexico EZH2 Inhibitors Market, By Type of Therapy, 2023-2033(USD Billion)
  15. Mexico EZH2 Inhibitors Market, By End Users, 2023-2033(USD Billion)
  16. Europe EZH2 Inhibitors Market, By Type of Therapy, 2023-2033(USD Billion)
  17. Europe EZH2 Inhibitors Market, By End Users, 2023-2033(USD Billion)
  18. Germany EZH2 Inhibitors Market, By Type of Therapy, 2023-2033(USD Billion)
  19. Germany EZH2 Inhibitors Market, By End Users, 2023-2033(USD Billion)
  20. France EZH2 Inhibitors Market, By Type of Therapy, 2023-2033(USD Billion)
  21. France EZH2 Inhibitors Market, By End Users, 2023-2033(USD Billion)
  22. U.K.  EZH2 Inhibitors Market, By Type of Therapy, 2023-2033(USD Billion)
  23. U.K.  EZH2 Inhibitors Market, By End Users, 2023-2033(USD Billion)
  24. Italy EZH2 Inhibitors Market, By Type of Therapy, 2023-2033(USD Billion)
  25. Italy EZH2 Inhibitors Market, By End Users, 2023-2033(USD Billion)
  26. Spain EZH2 Inhibitors Market, By Type of Therapy, 2023-2033(USD Billion)
  27. Spain EZH2 Inhibitors Market, By End Users, 2023-2033(USD Billion)
  28. Asia Pacific EZH2 Inhibitors Market, By Type of Therapy, 2023-2033(USD Billion)
  29. Asia Pacific EZH2 Inhibitors Market, By End Users, 2023-2033(USD Billion)
  30. Japan EZH2 Inhibitors Market, By Type of Therapy, 2023-2033(USD Billion)
  31. Japan EZH2 Inhibitors Market, By End Users, 2023-2033(USD Billion)
  32. China EZH2 Inhibitors Market, By Type of Therapy, 2023-2033(USD Billion)
  33. China EZH2 Inhibitors Market, By End Users, 2023-2033(USD Billion)
  34. India EZH2 Inhibitors Market, By Type of Therapy, 2023-2033(USD Billion)
  35. India EZH2 Inhibitors Market, By End Users, 2023-2033(USD Billion)
  36. South America EZH2 Inhibitors Market, By Type of Therapy, 2023-2033(USD Billion)
  37. South America EZH2 Inhibitors Market, By End Users, 2023-2033(USD Billion)
  38. Brazil EZH2 Inhibitors Market, By Type of Therapy, 2023-2033(USD Billion)
  39. Brazil EZH2 Inhibitors Market, By End Users, 2023-2033(USD Billion)
  40. The Middle East and Africa EZH2 Inhibitors Market, By Type of Therapy, 2023-2033(USD   Billion)
  41. The Middle East and Africa EZH2 Inhibitors Market, By End Users, 2023-2033(USD   Billion)
  42. UAE EZH2 Inhibitors Market, By Type of Therapy, 2023-2033(USD Billion)
  43. UAE EZH2 Inhibitors Market, By End Users, 2023-2033(USD Billion)
  44. South Africa EZH2 Inhibitors Market, By Type of Therapy, 2023-2033(USD Billion)
  45. South Africa EZH2 Inhibitors Market, By End Users, 2023-2033(USD Billion)

 

List of Figures 

  1. Global EZH2 Inhibitors Market Segmentation
  2. EZH2 Inhibitors Market: Research Methodology
  3. Market Size Estimation Methodology: Bottom-Up Approach
  4. Market Size Estimation Methodology: Top-down Approach
  5. Data Triangulation
  6. Porter’s Five Forces Analysis
  7. Value Chain Analysis
  8. Top investment pocket in the EZH2 Inhibitors Market
  9. Top Winning Strategies, 2023-2033
  10. Top Winning Strategies, By Development, 2023-2033(%)
  11. Top Winning Strategies, By Company, 2023-2033
  12. Moderate Bargaining power of Buyers
  13. Moderate Bargaining power of Suppliers
  14. Moderate Bargaining power of New Entrants
  15. Low threat of Substitution
  16. High Competitive Rivalry
  17. Top Player Positioning, 2023
  18. Market Share Analysis, 2023
  19. Restraint and Drivers:  EZH2 Inhibitors Market
  20. EZH2 Inhibitors Market Segmentation, By Type of Therapy
  21. EZH2 Inhibitors Market For Monotherapy, By Region, 2023-2033 ($ Billion)
  22.  EZH2 Inhibitors Market For Combination Therapy, By Region, 2023-2033 ($ Billion)
  23.  EZH2 Inhibitors Market Segmentation, By End Users
  24.  EZH2 Inhibitors Market For Hospitals, By Region, 2023-2033 ($ Billion)
  25.  EZH2 Inhibitors Market For Research Laboratories, By Region, 2023-2033 ($ Billion)
  26. EZH2 Inhibitors Market For Clinics, By Region, 2023-2033 ($ Billion)
  27. Merck: Net Sales, 2023-2033 ($ Billion)
  28. Merck: Revenue Share, By Segment, 2023 (%)
  29. Merck: Revenue Share, By Region, 2023 (%)
  30. Athenex: Net Sales, 2023-2033 ($ Billion)
  31. Athenex: Revenue Share, By Segment, 2023 (%)
  32. Athenex: Revenue Share, By Region, 2023 (%)
  33. Prelude Therapeutics: Net Sales, 2023-2033 ($ Billion)
  34. Prelude Therapeutics: Revenue Share, By Segment, 2023 (%)
  35. Prelude Therapeutics: Revenue Share, By Region, 2023 (%)
  36. Novartis: Net Sales, 2023-2033 ($ Billion)
  37. Novartis: Revenue Share, By Segment, 2023 (%)
  38. Novartis: Revenue Share, By Region, 2023 (%)
  39. AstraZeneca: Net Sales, 2023-2033 ($ Billion)
  40. AstraZeneca: Revenue Share, By Segment, 2023 (%)
  41. AstraZeneca: Revenue Share, By Region, 2023 (%)
  42. Silence Therapeutics: Net Sales, 2023-2033 ($ Billion)
  43. Silence Therapeutics: Revenue Share, By Segment, 2023 (%)
  44. Silence Therapeutics: Revenue Share, By Region, 2023 (%)
  45. Incyte: Net Sales, 2023-2033 ($ Billion)
  46. Incyte: Revenue Share, By Segment, 2023 (%)
  47. Incyte: Revenue Share, By Region, 2023 (%)
  48. Celgene: Net Sales, 2023-2033 ($ Billion)
  49. Celgene: Revenue Share, By Segment, 2023 (%)
  50. Celgene: Revenue Share, By Region, 2023 (%)
  51. Zymeworks.: Net Sales, 2023-2033 ($ Billion)
  52. Zymeworks.: Revenue Share, By Segment, 2023 (%)
  53. Zymeworks.: Revenue Share, By Region, 2023 (%)
  54. Janssen Biotech: Net Sales, 2023-2033 ($ Billion)
  55. Janssen Biotech: Revenue Share, By Segment, 2023 (%)
  56. Janssen Biotech: Revenue Share, By Region, 2023 (%)
  57. GSK: Net Sales, 2023-2033 ($ Billion)
  58. GSK: Revenue Share, By Segment, 2023 (%)
  59. GSK: Revenue Share, By Region, 2023 (%)
  60. Epizyme: Net Sales, 2023-2033 ($ Billion)
  61. Epizyme: Revenue Share, By Segment, 2023 (%)
  62. Epizyme: Revenue Share, By Region, 2023 (%)
  63. NantKwest: Net Sales, 2023-2033 ($ Billion)
  64. NantKwest: Revenue Share, By Segment, 2023 (%)
  65. NantKwest: Revenue Share, By Region, 2023 (%)
  66. Others: Net Sales, 2023-2033 ($ Billion)
  67. Others: Revenue Share, By Segment, 2023 (%)
  68. Others: Revenue Share, By Region, 2023 (%)

Buy Now

  • Access to only 1 person; cannot be shared; cannot be printed
  • Access for 2 to 5 users only within same department of one company
  • Access to a company wide audience; includes subsidiary companies or other companies within a group of companies

Premium Report Details

Base Year:2023
Tables & Figures:106
Pages:220
Countries covered:17
Companies covered::19
Forecast CAGR:CAGR of 12.82%
Request Discount

15% Free Customization

Share your Requirements

Request Customization

We Covered in Market

  • 24/7 Analyst Support
  • Worldwide Clients
  • Tailored Insights
  • Technology Evolution
  • Competitive Intelligence
  • Custom Research
  • Syndicated Market Research
  • Market Snapshot
  • Market Segmentation
  • Growth Dynamics
  • Market Opportunities
  • Regulatory Overview
  • Innovation & Sustainability

Connect with us

Need help to buy this report?

Inquiry Before Buy
We'll use cookies to improve and customize your experience if you continue to browse. Is it OK if we also use cookies to show you personalized ads?
Learn more and manage your cookies
Yes, Accept Cookies